Ishikawa T, Kakumu S, Yoshioka K, Wakita T, Shinagawa T, Ito Y
Third Department of Internal Medicine, Nagoya University School of Medicine, Japan.
J Clin Lab Immunol. 1991 Apr;34(4):151-6.
Hepatitis B virus (HBV)-associated nucleocapsid antigen (HB core and HB e) is believed to be a major target for T cell-mediated hepatocellular damage in chronic HBV carriers. Studies were undertaken to determine whether both nucleocapsid Ag could be recognized by T cell lines from peripheral blood mononuclear cells (PBMC) from patients with chronic hepatitis B. After cultivation in the presence of rHBcAg or purified HBeAg, growing cells were cloned by limiting dilution in the presence of PHA, IL-2 and allogenic feeder cells. Four HBcAg-reactive and three HBeAg-reactive T cell lines from two patients were generated by proliferation assays. None of the cell lines responded to HB surface Ag or PPD. Four lines were of the CD8+ CD11b- cytotoxic phenotype, two of the CD4+ Leu8- helper phenotype, and the remaining one consisted of mixed populations of CD4+ Leu8+ and CD4+ Leu8- cells. Cross-reactivity study showed that a HBcAg-induced CD4+ T cell line responded to HBeAg, and similarly a HBeAg-induced CD8+ T cell line responded to HBcAg. The reactions were inhibited by HLA class II antibody, but not by class I Ab.
乙肝病毒(HBV)相关的核衣壳抗原(HB核心抗原和HBe抗原)被认为是慢性HBV携带者中T细胞介导的肝细胞损伤的主要靶点。开展了一些研究以确定来自慢性乙型肝炎患者外周血单个核细胞(PBMC)的T细胞系是否能识别这两种核衣壳抗原。在rHBcAg或纯化的HBeAg存在的情况下进行培养后,在PHA、IL-2和同种异体饲养细胞存在的情况下通过有限稀释法对生长的细胞进行克隆。通过增殖试验从两名患者中产生了四个对HBcAg有反应的T细胞系和三个对HBeAg有反应的T细胞系。没有一个细胞系对HB表面抗原或PPD有反应。四个细胞系具有CD8 + CD11b - 细胞毒性表型,两个具有CD4 + Leu8 - 辅助表型,其余一个由CD4 + Leu8 + 和CD4 + Leu8 - 细胞的混合群体组成。交叉反应性研究表明,一个由HBcAg诱导的CD4 + T细胞系对HBeAg有反应,同样,一个由HBeAg诱导的CD8 + T细胞系对HBcAg有反应。这些反应被HLA II类抗体抑制,但不被I类抗体抑制。